8-KOther Events

IDEXX LABORATORIES INC /DE 8-K Report, Corporate Update (Mar 5, 2014)

Filed March 5, 2014For Securities:IDXX

Summary

This 8-K filing from IDEXX LABORATORIES INC /DE (IDXX) on March 5, 2014, reports on a pre-arranged securities trading plan adopted by CEO Jonathan W. Ayers on February 28, 2014. This plan, structured under Rule 10b5-1, allows Mr. Ayers to exercise and sell a portion of his stock options that are set to expire in February 2015. The primary purpose is to cover exercise prices and taxes associated with these options, along with personal financial planning. The plan outlines the intent to exercise up to 144,757 stock options and sell the resulting shares according to a predetermined schedule. These transactions are expected to occur between November 2014 and February 2015. Separately, Mr. Ayers also intends to exercise an additional 10,000 stock options outside of this plan by February 2015, retaining the shares received. Investors should note that actual transactions will be reported via Form 4 filings.

Key Highlights

  • 1IDEXX CEO Jonathan W. Ayers has adopted a Rule 10b5-1 trading plan for stock options.
  • 2The plan allows for the exercise and sale of up to 144,757 stock options set to expire in February 2015.
  • 3Primary objectives for the plan are to cover option exercise costs, taxes, and personal financial planning.
  • 4Transactions under the plan are scheduled to occur from November 2014 through February 2015.
  • 5Mr. Ayers also plans to exercise an additional 10,000 stock options outside the plan, retaining the shares.
  • 6These transactions are designed to manage option expiration and optimize personal financial strategy.
  • 7Actual trades will be disclosed through subsequent Form 4 filings with the SEC.

Frequently Asked Questions